Market Cap

COSMO Pharmaceuticals NV Market Capitalization:

€1.16 Billion

EUR as of July 1, 2024

US$1.25 Billion

business COSMO Pharmaceuticals NV Company Profile

COSMO Pharmaceuticals NV Main Stock Listing

FSX: C43

Market Capitalization History of COSMO Pharmaceuticals NV

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $808.65 B
Johnson & Johnson $350.63 B
Merck $318.75 B
AbbVie $295.34 B
AstraZeneca $236.45 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of COSMO Pharmaceuticals NV market cap

Date Market Cap YoY Change
Jan. 1, 2024 €974.1 M -2.66%
Jan. 1, 2023 €1.00 B 12.84%
Jan. 1, 2022 €886.8 M -27.33%
Jan. 1, 2021 €1.22 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

COSMO Pharmaceuticals NV Categories

Ireland languages Healthcare languages Drug Manufacturers—General
Ireland Healthcare Ireland Drug Manufacturers—General

Stocks & Indices

COSMO Pharmaceuticals NV has the following listings and related stock indices.


Stock: FSX: C43

Stock: SIX: COPN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.